Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.175 USD | -2.03% |
|
+5.07% | +2.11% |
06-27 | NEXGEL Secures Distribution Deal for SilverSeal Wound Dressing With Cintas | MT |
06-27 | Nexgel, Inc. to Supply Silverseal to Cintas Corporation | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 14.52 | 6.965 | 12.18 | 13.55 | - | - |
Enterprise Value (EV) 1 | 14.52 | 6.965 | 12.18 | 13.55 | 13.55 | 13.55 |
P/E ratio | -1.8 x | -1.47 x | -3.8 x | -4.03 x | - | 3.06 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 9.36 x | 3.4 x | 2.98 x | 1.87 x | 1.2 x | 0.82 x |
EV / Revenue | 9.36 x | 3.4 x | 2.98 x | 1.87 x | 1.2 x | 0.82 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -5,328,240 x | - | - | - | - | - |
FCF Yield | -0% | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 5,565 | 5,572 | 5,718 | 6,228 | - | - |
Reference price 2 | 2.610 | 1.250 | 2.130 | 2.175 | 2.175 | 2.175 |
Announcement Date | 21/03/22 | 28/03/23 | 01/04/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 1.551 | 2.048 | 4.089 | 7.229 | 11.32 | 16.48 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -2.57 | -3.348 | -3.477 | -3.327 | -0.019 | 4.501 |
Operating Margin | - | -165.7% | -163.48% | -85.03% | -46.02% | -0.17% | 27.31% |
Earnings before Tax (EBT) 1 | - | -4.31 | -4.746 | -3.188 | -3.361 | -0.019 | 4.501 |
Net income 1 | -2.264 | -4.31 | -4.746 | -3.157 | -3.361 | -0.019 | 4.501 |
Net margin | - | -277.89% | -231.74% | -77.21% | -46.49% | -0.17% | 27.31% |
EPS 2 | -0.0300 | -1.450 | -0.8500 | -0.5600 | -0.5400 | - | 0.7100 |
Free Cash Flow | - | -2.726 | - | - | - | - | - |
FCF margin | - | -175.76% | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 31/03/21 | 21/03/22 | 28/03/23 | 01/04/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 0.533 | 0.396 | 0.561 | 0.568 | 0.524 | 0.62 | 1.167 | 1.221 | 1.082 | 1.266 | 1.405 | 2.091 | 2.467 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -0.887 | -0.812 | -0.718 | -1.037 | -0.781 | -0.883 | -0.762 | -0.612 | -1.219 | -0.871 | -0.868 | -0.82 | -0.769 |
Operating Margin | -166.42% | -205.05% | -127.99% | -182.57% | -149.05% | -142.42% | -65.3% | -50.12% | -112.66% | -68.8% | -61.78% | -39.22% | -31.17% |
Earnings before Tax (EBT) 1 | -1.639 | -1.836 | -1.035 | -1.227 | -0.648 | -0.807 | -0.642 | -0.552 | -1.187 | -0.905 | -0.868 | -0.82 | -0.769 |
Net income 1 | -1.639 | -1.836 | -1.035 | -1.227 | -0.648 | -0.814 | -0.695 | -0.552 | -1.098 | -0.853 | -0.868 | -0.82 | -0.769 |
Net margin | -307.5% | -463.64% | -184.49% | -216.02% | -123.66% | -131.29% | -59.55% | -45.21% | -101.48% | -67.38% | -61.78% | -39.22% | -31.17% |
EPS 2 | -1.420 | -0.3300 | -0.1900 | -0.2200 | -0.1100 | -0.1500 | -0.1200 | -0.1000 | -0.2000 | -0.1400 | -0.1400 | -0.1300 | -0.1200 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 21/03/22 | 13/05/22 | 10/08/22 | 08/11/22 | 28/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 01/04/24 | 13/05/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | -2.73 | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | 0.27 | - | - | - | - | - |
Capex / Sales | - | 17.34% | - | - | - | - | - |
Announcement Date | 31/03/21 | 21/03/22 | 28/03/23 | 01/04/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.11% | 13.55M | |
+55.95% | 819B | |
+43.36% | 638B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+17.17% | 242B | |
+2.74% | 225B | |
+13.37% | 217B | |
+8.91% | 168B |
- Stock Market
- Equities
- NXGL Stock
- Financials NEXGEL, Inc.